Two main types of autoimmune pancreatitis (AIP) have been described: type 1, linked to IgG4-related disease, and type 2, ...

The 2025 Congress of Clinical Rheumatology West will feature expanded immunology and young investigator programs, as well as ...

Melinda French Gates will contribute $50 million to women’s health research via Pivotal. Photo by Taylor Hill/FilmMagic Melinda French Gates is doubling down on her commitment to women’s health. The ...

A pizza shop with 30 delivery people ought to be able to deliver a lot of pizzas—if their cars don't break down on the way. Likewise, genes that produce a lot of messenger RNA (mRNA) molecules can ...

The prevalence of AILD and IBD supports the gut-liver axis theory. Inflammatory bowel disease (IBD) and autoimmune liver disease (AILD) prevalence are significantly correlated, according to a study in ...

Background: Acute pancreatitis (AP) is a common gastrointestinal disorder, with organ failure being the primary cause of mortality. This study evaluates the combined score of C-reactive protein level ...

SACQ patients were more likely to have higher IgG4 levels at baseline and a higher prevalence of the proliferative subtype. Similar relapse rates were observed between SACQ and SQCQ (serologically ...

The study, titled “Association of IgG4-Related Disease with Human Inborn Errors of Immunity,” involved 18 patients diagnosed with IgG4-RD, all of whom underwent Whole Exome Sequencing (WES) to examine ...

ALBUQUERQUE, N.M. – With cold, flu and COVID season just around the corner, many people are looking to get vaccinated. However, across New Mexico, you might have trouble getting the COVID shot, ...

- Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease - - Additional $150 million associated with the upcoming results of the ...

We returned from the Labor Day holiday to a spate of intriguing deals, including two that could surpass $2 billion: Vertex’s new pact with Enlaza for autoimmune disease—which the Casgevy maker hopes ...